the science of very small substances, which is commonly known as nanotechnology, is poised to have an immense influence in pharmaceutical packaging. it will also enable it to get innovative and novel generation packaging products to the market. in the pharmaceutical industry, packaging has gone through main modifications in the last decade. the beginning of innovative drug delivery systems and the advancement of innovative biochemical compounds have resulted in a requirement not only for more protection against things such as light, oxygen, mechanical forces and moisture, but also for wrapping forms to perform a more essential role in the process of drug delivery. today, packaging design offers shelf life and stability to the delivery system and the drug, which becomes essential to the convenience, safety and compliance of drug use. fundamental categories of applications of nanotechnology and functionalities emerge in development of pharmaceutical a.k.a. pharma packaging when it comes to enhancement of barriers of plastic materials&rsquo inclusion of active components that can provide functional attributes away from those of traditional active packaging as well as signaling and sensing of relevant information. as per the information mentioned in a currently published report by irap, inc. online available at www.innoresearch.net, ph101 nanoenabled packaging for the pharmacetical industry &ndash a global technology, industry and market analysis, the entire turnover for nanoenabled packaging for pharmaceuticals is 3.8 billion in 2009. this turnover is expected to increase to 8.1 billion by 2014. the expansion will be at a compound annual growth rate commonly known as cagr of 16.5 right from 2009 to 2014. blister packaging for pharmaceutical will display favourable expansion in worldwide demand based on flexibility to clinical trial, compliance, and unit dose, overthecounter and institutional drugs. advancements in the switch over features of processing equipment will also help expansion by making blister packaging more budgetfriendly in tiny amount drug applications. in 2008, for nanoenabled packaging for blisters the universal market for blisters was 941 million, and by 2014, is likely to expand to 2.10 billion. universal demand for prefillable syringes and prefillable inhalers will create the greatest growth opportunities amongst all pharma packaging products, depending upon the performance advantages in delivery of drug as well as the introduction of innovative bioengineered medicines. plastic bottles will uphold the biggest share of universal demand, based on versatility, low cost, ongoing quality, and availability and design improvements. universal market expansion for pharmaceutical accessories and closures will be dominated by senior friendly, child resistant, and dispensing closures acquiescenceenhanced prescription containers anticounterfeit and tamperevident accessories, and high visibility labels. for these products, requirement will gain from stricter industry and government standards covering the security, safety as well as ease of use features of containers of drug. the europe and u.s. will remain the biggest customers of packaging for pharmaceutical, as their superior drugproducing divisions introduce innovative therapies with specific packaging requirements. japan still have the big share of the market of asia pacific 65, but its contribution is likely to reduce as india evolves into a fastexpanding market of pharmaceutical packaging as sectors of drugproducing are diversified and upgraded, particularly in the field of generic drugs. growth opportunities of china will be amongst the strongest, depending on rapidly increasing pharmaceutical production capabilities there and the phasingin of a administration program intended to upgrade the integrity and quality of nationwide produced medicines. source of information httpwww.innoresearch.netpressrelease.aspxid22
